Method for loading platelet-rich plasma and mesenchymal stem cells on biological scaffold

By loading platelet-rich plasma and bone marrow mesenchymal stem cells on collagen biological scaffolds, the problem of antibody response caused by PRP decomposition and thrombin in tissue repair is solved, and efficient tissue repair and avoidance of immune responses is achieved.

CN118987368AInactive Publication Date: 2024-11-22STAR SPORTS MEDICINE CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411463426.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-21
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Prior Art When applying liquid form of platelet-rich plasma (PRP) for tissue repair, the presence of plasmin may lead to the decomposition and loss of PRP, and gelation of bovine thrombin may trigger an antibody response, resulting in postoperative bleeding. or autoimmune syndrome.

Method used

Platelet-rich plasma and bone marrow mesenchymal stem cells are mixed with anticoagulants, and after forming a mixed solution, it is added dropwise or injected to the surface or inside of the collagen biological scaffold. Its porous structure is used to absorb and protect PRP, load BMSCs, and build a repair system.

Benefits of technology

The porous structure of the collagen biological scaffold absorbs and protects PRP, prevents plasmin, achieves efficient repair of the damaged site, and provides biological scaffolds, seed cells and biological factors to simplify operations and ensures the effectiveness of the repair system.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention belongs to the technical field of regenerative medicine, and particularly relates to a method for loading platelet-rich plasma (PRP) and bone marrow mesenchymal stem cells (BMSCs) on a biological scaffold. The method comprises the following steps: respectively mixing PRP and BMSCs with an anticoagulant, then continuing to circularly mix, and finally dropwise adding or injecting the PRP-BMSCs mixed solution after mixing to a biological scaffold and infiltrating the biological scaffold. According to the invention, the collagen biological scaffold is used as a carrier of the PRP, and the specific porous structure of the collagen biological scaffold can absorb a large amount of PRP, protect the PRP from plasmin and load the BMSCs, so that a repair system containing the biological scaffold, seed cells and biological factors at the same time is constructed, the biological function of the PRP is practically exerted, and the repair effect of the PRP is improved. The efficient repair of the damaged part is realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of regenerative medicine, and in particular relates to a method for loading platelet-rich plasma (PRP) and bone marrow mesenchymal stem cells (BMSCs) on a biological scaffold. Background Art

[0002] Platelet-rich plasma (PRP) is a recently discovered important platelet concentrate that contains a large amount of growth factors that can stimulate the repair of tissue defects. It is a hot research topic in the fields of dentistry and orthopedics (Fufa D, Shealy B, Jacobson M, et al. Activation of platelet-rich plasma using soluble type I collagen[J]. Journal of Oral and Maxillofacial Surgery, 2008, 66(4):684-690). When applied to the injured area, the growth factors such as PDGF, TGF-β, IGF, EGF, VEGF contained in PRP can promote the increase of fibroblast DNA synthesis, increase collagen synthesis and extracellular matrix secretion, and improve the efficiency of tissue damage repair (Joshi SM, Mastrangelo AN, Magarian EM, et al. Collagen-platelet composite enhances biomechanical and histologic healing of the porcineanterior cruciate ligament[J]. The American journal of sports medicine, 2009,37(12): 2401-2410).

[0003] However, when PRP in liquid form is applied to the oral cavity or anterior cruciate ligament, the presence of plasmin may cause the decomposition and loss of PRP. One of the existing solutions is to complete the gelation of PRP through the coagulation mechanism. This gelation is currently accomplished using bovine thrombin; although bovine thrombin is a potent platelet activator, it can also induce the development of antibodies against thrombin, prothrombin, factor V, and cardiolipin, which can create clinical problems ranging from postoperative bleeding to a lupus-like autoimmune syndrome (Fleming BC, Spindler KP, Palmer MP, et al. Collagen-platelet composites improve the biomechanical properties of healing anterior cruciate ligament grafts in a porcine model[J]. The American journalof sports medicine, 2009, 37(8): 1554-1563; Murray MM, Palmer M, Abreu E, et al. Platelet-rich plasma alone is not sufficient to enhance suture repair of the ACL in skeletally immature animals: an in vivo study[J]. Journal ofOrthopaedic Research, 2009, 27(5): 639-645; Spindler KP, Murray MM, Carey JL, et al. The use of platelets to affect functional healing of an anteriorcruciate ligament (ACL) autograft in a caprine ACL reconstruction model[J]. Journal of Orthopedic Research, 2009, 27(5): 631-638).

[0004] Therefore, based on this, the technical solution of the present invention is proposed. Summary of the invention

[0005] In order to solve the problems existing in the prior art, the present invention provides a method for loading platelet-rich plasma and bone marrow mesenchymal stem cells on a biological scaffold, the method comprising the following steps: (1) mixing platelet-rich plasma (PRP) and bone marrow mesenchymal stem cells (BMSCs) with an anticoagulant, respectively, to obtain a platelet-rich plasma-anticoagulant (PRP-anticoagulant) mixed solution and a bone marrow mesenchymal stem cell-anticoagulant (BMSCs-anticoagulant) mixed solution, respectively; (2) Circulating and mixing the platelet-rich plasma-anticoagulant mixture with the bone marrow mesenchymal stem cell-anticoagulant mixture to obtain a platelet-rich plasma-bone marrow mesenchymal stem cell mixture (PRP-BMSCs); (3) adding the platelet-rich plasma-bone marrow mesenchymal stem cell mixture dropwise onto the surface of the collagen bioscaffold or injecting it into the interior of the collagen bioscaffold; (4) After the collagen bioscaffold is completely infiltrated by the platelet-rich plasma-bone marrow mesenchymal stem cell mixture, a collagen bioscaffold loaded with platelet-rich plasma and bone marrow mesenchymal stem cells is obtained.

[0006] Preferably, in step (1), the anticoagulant includes but is not limited to trisodium citrate, heparin, ethylenediaminetetraacetate or sodium oxalate.

[0007] Preferably, in step (1), in the platelet-rich plasma-anticoagulant mixture, the volume ratio of platelet-rich plasma to anticoagulant is 5:0.1, and the concentration of the anticoagulant is 1-15 wt.%.

[0008] Preferably, in step (1), in the bone marrow mesenchymal stem cell-anticoagulant mixture, the volume ratio of bone marrow mesenchymal stem cells to anticoagulant is 5:0.1, and the concentration of the anticoagulant is 1-15 wt.%.

[0009] Preferably, in step (2), the number of cyclic mixing is 5 to 20 times.

[0010] Preferably, in step (2), the temperature of the circulating mixing is 20-37°C.

[0011] Preferably, in step (3), the dripping rate is 10 to 60 drops / min.

[0012] Preferably, in step (3), the injection rate is 0.5-3 mL / min.

[0013] The beneficial effects of the present invention are: The present invention adopts collagen bioscaffold as a carrier of PRP. The unique porous structure of the collagen bioscaffold can absorb a large amount of PRP and protect it from the action of plasmin. At the same time, it can load BMSCs. In this way, a repair system including a bioscaffold, seed cells, and biological factors is constructed, which effectively exerts the biological function of PRP and realizes efficient repair of the damaged part.

[0014] In addition, the method of the present invention is simple to operate and can be completed with only a syringe and a syringe connecting tube. The bioscaffold complex loaded with PRP and BMSCs already has the three elements required for tissue engineering, namely, bioscaffold, seed cells and biological factors, and can be directly applied to the repair and regeneration of damaged tissues. DETAILED DESCRIPTION

[0015] To make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be described in detail below. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other implementation methods obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention.

[0016] Example 1 This embodiment provides a method for loading platelet-rich plasma and bone marrow mesenchymal stem cells on a biological scaffold, the method comprising the following steps: (1) Using two syringes preloaded with trisodium citrate anticoagulant (0.1 mL, concentration 15 wt.%), 5 mL of PRP and 5 mL of BMSCs were drawn respectively to obtain a PRP-trisodium citrate anticoagulant mixture and a BMSCs-trisodium citrate anticoagulant mixture, respectively; (2) Connect the two syringes through the syringe connecting tube, push the two syringes alternately at 20°C for 5 cycles, and finally transfer all the PRP-BMSCs mixed solution into one syringe; (3) Remove the syringe and evenly add the PRP-BMSCs mixture to the surface of the collagen bioscaffold at a rate of 20 drops / min. After the collagen bioscaffold is completely infiltrated by the PRP-BMSCs mixture, a collagen bioscaffold loaded with PRP and BMSCs can be obtained.

[0017] Example 2 This embodiment provides a method for loading platelet-rich plasma and bone marrow mesenchymal stem cells on a biological scaffold, the method comprising the following steps: (1) Using two syringes preloaded with heparin anticoagulant (0.1 mL, concentration 1 wt.%), draw 5 mL of PRP and 5 mL of BMSCs, respectively, to obtain a PRP-heparin anticoagulant mixture and a BMSCs-heparin anticoagulant mixture, respectively; (2) Connect the two syringes through the syringe connecting tube, push the two syringes alternately at 20°C for 10 cycles, and finally transfer all the PRP-BMSCs mixed solution into one syringe; (3) Remove the syringe and evenly add the PRP-BMSCs mixture to the surface of the collagen bioscaffold at a rate of 40 drops / min. After the collagen bioscaffold is completely infiltrated by the PRP-BMSCs mixture, a collagen bioscaffold loaded with PRP and BMSCs can be obtained.

[0018] Example 3 This embodiment provides a method for loading platelet-rich plasma and bone marrow mesenchymal stem cells on a biological scaffold, the method comprising the following steps: (1) Using two syringes preloaded with EDTA anticoagulant (0.1 mL, concentration 4 wt.%), 5 mL of PRP and 5 mL of BMSCs were drawn respectively to obtain a PRP-EDTA anticoagulant mixture and a BMSCs-EDTA anticoagulant mixture, respectively; (2) Connect the two syringes through the syringe connecting tube, push the two syringes alternately at 25°C for 5 cycles, and finally transfer all the PRP-BMSCs mixed solution into one syringe; (3) Remove the syringe and inject the PRP-BMSCs mixture into the center of the collagen bioscaffold at a rate of 1 mL / min. After the collagen bioscaffold is completely infiltrated by the PRP-BMSCs mixture, a collagen bioscaffold loaded with PRP and BMSCs can be obtained.

[0019] Example 4 This embodiment provides a method for loading platelet-rich plasma and bone marrow mesenchymal stem cells on a biological scaffold, the method comprising the following steps: (1) Using two syringes preloaded with sodium oxalate anticoagulant (0.1 mL, concentration 10 wt.%), draw 5 mL of PRP and 5 mL of BMSCs, respectively, to obtain a PRP-sodium oxalate anticoagulant mixture and a BMSCs-sodium oxalate anticoagulant mixture; (2) Connect the two syringes through the syringe connecting tube, push the two syringes alternately at 37°C for 10 cycles, and finally transfer all the PRP-BMSCs mixed solution into one syringe; (3) Remove the syringe and inject the PRP-BMSCs mixture into the center of the collagen bioscaffold at a rate of 3 mL / min. After the collagen bioscaffold is completely infiltrated by the PRP-BMSCs mixture, a collagen bioscaffold loaded with PRP and BMSCs can be obtained.

[0020] Effect verification example 1. The influence of different feeding methods on experimental results Comparing Example 1 (drip method) with Example 3 (injection method), it can be found that in the drip method, the PRP-BMSCs mixture is evenly dripped on the surface of the stent, so it is equivalent to having multiple diffusion centers on the surface of the stent, which can make the PRP-BMSCs mixture more evenly dispersed in the stent. In the injection method, there is only one diffusion center inside the biological stent, and the injected PRP-BMSCs mixture diffuses from the center of the biological stent to the surroundings. After the addition is completed, it may take some time to wait for subsequent experiments depending on the injection speed and the final diffusion situation. However, when the feeding speed is 20 drops / min or 1mL / min, the difference between the products obtained by the two feeding methods is not large, and both can be used for subsequent experiments.

[0021] 2. Effect of different injection speeds on experimental results On the basis of Example 3, the injection speed was changed to 0.5mL / min and 3mL / min respectively. It can be found that when the injection speed is 0.5mL / min, the injected PRP-BMSCs mixture can be evenly diffused in the collagen scaffold due to the slow injection speed. When the injection speed is 3mL / min, the injection speed is relatively fast. Since the diffusion of the PRP-BMSCs mixture takes time, the concentration of the PRP-BMSCs mixture in the center of the collagen scaffold is higher at the end of the injection, which is specifically manifested as the hardness of the center of the collagen scaffold is less than that of the surrounding area (the reason is that the strength of the dry collagen scaffold with higher strength will decrease after absorbing the liquid and turning into a wet state). Therefore, in order to ensure the later experimental operation and repair effect, the biological scaffold prepared under the condition of slow injection speed should be used for the experiment. However, the injection speed cannot be too slow, because collagen itself has the ability to coagulate blood. When the injection speed is less than 0.1 mL / min, due to the slow injection speed, part of the PRP-BMSCs mixture will coagulate, so the injection speed is selected to be 0.5-3 mL / min.

[0022] The above is only a specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention should be based on the protection scope of the claims.

Claims

1. A method for loading platelet-rich plasma and bone marrow mesenchymal stem cells onto a biological scaffold, characterized in that: The method comprises the following steps: (1) mixing platelet-rich plasma and bone marrow mesenchymal stem cells with an anticoagulant, respectively, to obtain a platelet-rich plasma-anticoagulant mixed solution and a bone marrow mesenchymal stem cell-anticoagulant mixed solution, respectively; (2) Circulating and mixing the platelet-rich plasma-anticoagulant mixture with the bone marrow mesenchymal stem cell-anticoagulant mixture to obtain a platelet-rich plasma-bone marrow mesenchymal stem cell mixture; (3) adding the platelet-rich plasma-bone marrow mesenchymal stem cell mixture dropwise onto the surface of the collagen bioscaffold or injecting it into the interior of the collagen bioscaffold; (4) After the collagen bioscaffold is completely infiltrated by the platelet-rich plasma-bone marrow mesenchymal stem cell mixture, a collagen bioscaffold loaded with platelet-rich plasma and bone marrow mesenchymal stem cells is obtained.

2. The method for loading platelet-rich plasma and bone marrow mesenchymal stem cells onto a biological scaffold according to claim 1, characterized in that: In step (1), the anticoagulant includes trisodium citrate, heparin, ethylenediaminetetraacetate or sodium oxalate.

3. The method for loading platelet-rich plasma and bone marrow mesenchymal stem cells onto a biological scaffold according to claim 1, characterized in that: In step (1), in the platelet-rich plasma-anticoagulant mixture, the volume ratio of platelet-rich plasma to anticoagulant is 5:0.1, and the concentration of the anticoagulant is 1-15 wt.%.

4. The method for loading platelet-rich plasma and bone marrow mesenchymal stem cells onto a biological scaffold according to claim 1, characterized in that: In step (1), in the bone marrow mesenchymal stem cell-anticoagulant mixture, the volume ratio of bone marrow mesenchymal stem cells to anticoagulant is 5:0.1, and the concentration of the anticoagulant is 1-15wt.%.

5. The method for loading platelet-rich plasma and bone marrow mesenchymal stem cells onto a biological scaffold according to claim 1, characterized in that: In step (2), the number of cyclic mixing is 5 to 20 times.

6. The method for loading platelet-rich plasma and bone marrow mesenchymal stem cells onto a biological scaffold according to claim 1, characterized in that: In step (2), the temperature of the circulating mixing is 20-37°C.

7. The method for loading platelet-rich plasma and bone marrow mesenchymal stem cells onto a biological scaffold according to claim 1, characterized in that: In step (3), the dripping rate is 10 to 60 drops / min.

8. The method for loading platelet-rich plasma and bone marrow mesenchymal stem cells onto a biological scaffold according to claim 1, characterized in that: In step (3), the injection rate is 0.5~3mL / min.

Citation Information

Patent Citations

  • Synovial mesenchymal stem cell and PRP combined preparation for repairing articular cartilage injury as well as preparation method and application thereof

    CN112294845A

  • Composite repair gel containing umbilical cord mesenchymal stem cells and platelet-rich plasma for injection

    CN112402364A

  • Composition for wound repair as well as preparation method and application thereof

    CN113995772A

  • Composite scaffold material for slowly releasing platelet-rich plasma as well as preparation method and application of composite scaffold material

    CN115400270A

  • Injection type tissue engineering bone renovation material and construct method thereof

    CN1923300A